Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Semnur Pharmaceuticals, Inc.(SMNR) the EBIT is -4.224 M (-322.8%);the EPS is -0.0189 (-278%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B322.82%
----
----
EPS
-0.0189278.02%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf